Showing 1 - 10 of 545
We consider a policy game between a high-income country hosting a drug innovator and a low-income country hosting a drug imitator. The low-income country chooses whether to enforce an International Patent Regime (strict IPR) or not (weak IPR) and the high-income country chooses whether to allow...
Persistent link: https://www.econbiz.de/10011115487
India’s health care and health financing provision is characterized by too little Government spending on health, meager … level of health insurance penetration in India. Health insurance cover is found to be a strong determinant of modern health …
Persistent link: https://www.econbiz.de/10011257944
aftermath of the Southeast Asian crisis, the limitation of the liberal capital regime for a developing country like India is … often highlighted in the literature. However, the probable impact of introducing KAC on CAB in India generally is discussed … theoretically. Though some of the existing studies in India have earlier focused on this research question, they have done so by …
Persistent link: https://www.econbiz.de/10014194754
The purpose of this paper is to examine the progress in socioeconomic conditions across the major states of India by …
Persistent link: https://www.econbiz.de/10014154852
In recent years there has been a rapid and sustained growth of the service sector in the Indian economy. But unfortunately, while the importance of the services is growing statistical data and other relevant information of the services are abysmally low. There are problems relating to the...
Persistent link: https://www.econbiz.de/10014187326
This third overview of EU competition and sector-specific regulatory jurisprudential and case law developments with a nexus to Poland covers the years 2010 and 2011. This period of time is worth noting for several reasons. First, EU courts delivered a significant number of judgments in...
Persistent link: https://www.econbiz.de/10011260409
distinction seems to emerge. On the one hand, systems that rely on market-based competition in pharmaceuticals promote a clear …
Persistent link: https://www.econbiz.de/10005034975
, and the activities of Shaman Pharmaceuticals in Latin America and Africa. It provides the details, discusses what each …
Persistent link: https://www.econbiz.de/10005621738
Within the debate about the rise of costs in the German health system, the argument has put forth that patients' excessive demand for benefits is caused by the existence of a moral hazard problem. One way of influencing an insured person's consumer behaviour is the introduction of several...
Persistent link: https://www.econbiz.de/10008765092
monopolistic manufacturer of pharmaceuticals and a foreign exclusive distributor we, first, show that parallel trade reduces the …
Persistent link: https://www.econbiz.de/10011107968